Vyne Therapeutics Financials

Earnings View

Profitability View

Liquidity View

Fundamentals View

Competition View

Vyne Therapeutics Stock Summary

Vyne Therapeutics competes with Akari Therapeutics, Salarius Pharmaceuticals, SAB Biotherapeutics, GeoVax Labs, and Unicycive Therapeutics. VYNE Therapeutics Inc., a pharmaceutical company, focuses on developing various therapeutics for the treatment of immuno-inflammatory conditions. VYNE Therapeutics Inc. was founded in 2003 and is based in Bridgewater, New Jersey. Vyne Therapeutics operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 28 people.

Vyne Therapeutics Key Financial Ratios

Vyne Therapeutics Key Balance Sheet Accounts

Vyne Therapeutics Key Income Statement Accounts

Vyne Therapeutics Key Cash Accounts

Vyne Financial Ratios Relationships

Comparative valuation techniques use various fundamental indicators to help in determining Vyne Therapeutics's current stock value. Our valuation model uses many indicators to compare Vyne Therapeutics value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Vyne Therapeutics competition to find correlations between indicators driving Vyne Therapeutics's intrinsic value. More Info.Vyne Therapeutics is rated fifth in return on equity category among its peers. It is rated below average in return on asset category among its peers . At present, Vyne Therapeutics' Return On Equity is projected to slightly decrease based on the last few years of reporting. Comparative valuation analysis is a catch-all technique that is used if you cannot value Vyne Therapeutics by discounting back its dividends or cash flows. It compares the stock's price multiples to nearest competition to determine if the stock is relatively undervalued or overvalued.

Vyne Therapeutics Systematic Risk

Today, most investors in Vyne Therapeutics Stock are looking for potential investment opportunities by analyzing not only static indicators but also various Vyne Therapeutics' growth ratios. Consistent increases or decreases in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's growth growth rates may not be enough to decide which company is a better investment. That's why investors frequently use static breakdown of Vyne Therapeutics growth as a starting point in their analysis.

Along with financial statement analysis, the daily predictive indicators of Vyne Therapeutics help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Vyne Therapeutics. We use our internally-developed statistical techniques to arrive at the intrinsic value of Vyne Therapeutics based on widely used predictive technical indicators. In general, we focus on analyzing Vyne Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Vyne Therapeutics's daily price indicators and compare them against related drivers.

When running Vyne Therapeutics' price analysis, check to measure Vyne Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Vyne Therapeutics is operating at the current time. Most of Vyne Therapeutics' value examination focuses on studying past and present price action to predict the probability of Vyne Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Vyne Therapeutics' price. Additionally, you may evaluate how the addition of Vyne Therapeutics to your portfolios can decrease your overall portfolio volatility.